Company profile: Build Clinical
1.1 - Company Overview
Company description
- Provider of a HIPAA-compliant platform and services to accelerate clinical research patient recruitment, including custom digital ads on search engines, health websites, and social media; study-specific landing pages; pre-screen questionnaires; real-time participant data management; monthly analytics reporting; and 24/7 support.
Products and services
- Digital Advertising Campaigns: Custom advertisements deployed across search engines, health websites, and social media platforms to engage prospective participants for clinical research enrollment
- Technology Platform: A HIPAA-compliant system enabling research teams to view participant responses and manage study data in real-time for clinical research recruitment oversight
- Study-Specific Landing Pages: Customized pages where participants learn about the research study and submit their information to express interest in participation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Build Clinical
Sterling Pharma Solutions
HQ: United Kingdom
Website
- Description: Provider of small molecule API development and manufacturing services for the global pharmaceutical industry, from pre-clinical to commercial. Offers ADC pre-clinical bioconjugation services with potent cytotoxin handling; PDMO® collaborative API development and integrated project management; hazardous chemistry; high potency and controlled substance API manufacturing; and peptide API development with large-scale chromatography.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sterling Pharma Solutions company profile →
CoreRx
HQ: United States
Website
- Description: Provider of contract pharmaceutical drug product development services to pharma and biotech, delivering cGMP solutions for dosage form development. Offerings include preformulation, formulation, analytical and stability services, GMP manufacturing and packaging, modified-release dosage forms, and oral solids (tablets and capsules) including immediate and controlled release.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CoreRx company profile →
Birgi Mefar
HQ: Turkey
Website
- Description: Provider of contract manufacturing of sterile parenteral solutions and suspensions, filling into ampoules, vials, lyo vials, pre-filled syringes and blow-fill-seal containers; manufacturer of primary packaging producing empty ampoules and vials from clear and amber glass tubing; lab services for stability studies, analytical method and process validation with scale-up; cGMP blistering, labeling, track and trace; GMP cold chain storage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Birgi Mefar company profile →
Veranova
HQ: United States
Website
- Description: Provider of research, development, and manufacturing of sophisticated, complex active pharmaceutical ingredients (APIs) for pharmaceutical and biotech industries, applying scientific expertise and diversified talent to create fresh approaches to resolving business issues and enhancing stakeholder value.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Veranova company profile →
Nordic Bioscience
HQ: Denmark
Website
- Description: Provider of ECM-focused biomarker technologies and services for precision drug development, including Protein Fingerprint technology to quantify extracellular matrix fragments in blood, laboratory biomarker analysis for clinical trials, the PRO-C3 biomarker for type III collagen formation, and the GRIPonMASH platform for early MASH detection and management with AI-based decision support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nordic Bioscience company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Build Clinical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Build Clinical
2.2 - Growth funds investing in similar companies to Build Clinical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Build Clinical
4.2 - Public trading comparable groups for Build Clinical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →